L-Hist Mont FX Tablet is a combination medication containing Montelukast 10 mg and Fexofenadine 120 mg, formulated to provide effective relief from allergic conditions. Montelukast, a leukotriene receptor antagonist, works by blocking substances called leukotrienes that cause inflammation, bronchoconstriction, and mucus production in the airways, making it particularly useful in managing asthma and allergic rhinitis. Fexofenadine, a second-generation antihistamine, selectively inhibits peripheral H1 receptors, thereby reducing symptoms such as sneezing, itching, watery eyes, and nasal congestion without causing significant sedation. The synergistic action of these two agents offers comprehensive control over allergic symptoms, improving patient comfort and quality of life. L-Hist Mont FX is indicated for the treatment of seasonal allergic rhinitis, chronic idiopathic urticaria, and as an adjunct in asthma management. It is generally well tolerated, with a low incidence of adverse effects; however, patients should be monitored for potential side effects such as headache, dizziness, or gastrointestinal discomfort. This combination therapy should be used under medical supervision, especially in individuals with pre-existing hepatic or renal impairment. L-Hist Mont FX Tablet provides a convenient and effective therapeutic option for patients requiring dual-action allergy management.